Transmembrane routes of cationic liposome-mediated gene delivery using human throat epidermis cancer cells

Biotechnol Lett. 2014 Jan;36(1):1-7. doi: 10.1007/s10529-013-1325-0. Epub 2013 Sep 26.

Abstract

For studying the mechanism of cationic liposome-mediated transmembrane routes for gene delivery, various inhibitors of endocytosis were used to treat human throat epidermis cancer cells, Hep-2, before transfection with Lipofectamine 2000/pGFP-N2 or Lipofectamine 2000/pGL3. To eliminate the effect of inhibitor toxicity on transfection, the RLU/survival rate was used to represent the transfection efficiency. Chlorpromazine and wortmannin, clathrin inhibitors, decreased transfection efficiency by 44 % (100 μM) and 31 % (100 nM), respectively. At the same time, genistein, a caveolin inhibitor, decreased it by 30 % (200 μM). Thus combined transmembrane routes through the clathrin and caveolae-mediated pathways were major mechanisms of cell uptake for the cationic liposome-mediated gene delivery. After entering the cells, microtubules played an important role on gene delivery as vinblastine, a microtubulin inhibitor, could reduce transfection efficiency by 41 % (200 nM).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cations / chemistry
  • Cations / metabolism
  • Caveolins / antagonists & inhibitors
  • Caveolins / metabolism
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Drug Delivery Systems
  • Endocytosis / drug effects
  • Endocytosis / physiology*
  • Gene Transfer Techniques*
  • Genistein / pharmacology
  • Humans
  • Liposomes / chemistry
  • Liposomes / metabolism*
  • Luciferases / genetics
  • Luciferases / metabolism
  • Microtubules / drug effects
  • Pharyngeal Neoplasms
  • Transfection
  • Vinblastine / pharmacology

Substances

  • Cations
  • Caveolins
  • Liposomes
  • Vinblastine
  • Genistein
  • Luciferases